US Patent RE38916 APC Antibodies
Patent RE38916 was granted and assigned to The Johns Hopkins Hospital on December, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 25 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 22 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Nov, 2023
Golden AI
Edits made to:
Infobox (+20 properties)
Article (+370 characters)
Article
Patent abstract
A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alexander Fred Markham0
Andrew Thilveris0
Bert Vogelstein0
Geoff Joslyn0
Hans Albertsen0
Joanna Groden0
Kenneth W. Kinzler0
Mary Carlson0
Philip John Hedge0
Rakesh Anand0
Raymond L. White0
Yusuka Nakamura0
Date of Patent
December 6, 2005
0Patent Application Number
094424890
Date Filed
November 18, 1999
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent RE38916 APC Antibodies
Find more entities like US Patent RE38916 APC Antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
